Sprinkles help the medicine go down
US regulators have found a new 'hundreds and thousands'-like drug treatment to be very palatable.
Archives for October 2, 2007
SAFC bets on drug conjugates with new manufacturing suite
SAFC has announced its plans to build a new high potency conjugation suite at its Missouri manufacturing plant in order to target pharma clients developing novel anti-cancer drug conjugates.
BMS takeover speculation mounts, again
Investors in Bristol-Myers Squibb were in a frisson of excitement earlier this week as speculation mounted - not for the first time - that the firm could soon become the target of a major pharmaceutical acquisition.
Sperm stopped in their tracks by vaginal gel contraceptive
Forget diamonds, a new vaginal gel contraceptive could be the 21st Century girl's new best friend with the ability to be applied up to 18 hours before a naughty rendezvous.
CRO supremacy in clinical research raises concerns
While contract research organisations (CROs) now dominate the clinical trials market, questions are being raised about the risks of 'commercialising' clinical studies, according to new research.
Recordati adopts Orphan Europe
Eighty-year-old Italian pharma company Recordati believes its future lies in rare diseases and has put its money where its mouth is by spending €135m on speciality firm Orphan Europe.